NFKB1 and cystic fibrosis: These studies provide insight into the mechanism of noxious inflammatory response in CF, Supporting studies also provide evidence that SERCA2 could regulate NF-κB and that modulation of SERCA2 could be a potential therapeutic strategy for treatment of CF.